8-K
Current Report
Atara Biotherapeutics, Inc. Filed Acc 0000950170-25-030832
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading atra-20250303.htm…